Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report

المؤلفون المشاركون

Mitropoulos, Panagiotis G.
Parikakis, Efstratios A.
Amariotakis, Georgios A.
Moschos, Marilita M.
Chatziralli, Irini P.
Peponis, Vasileios G.

المصدر

Case Reports in Ophthalmological Medicine

العدد

المجلد 2014، العدد 2014 (31 ديسمبر/كانون الأول 2014)، ص ص. 1-6، 6ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2014-11-23

دولة النشر

مصر

عدد الصفحات

6

التخصصات الرئيسية

الأمراض

الملخص EN

Purpose.

To present the case of a 27-year-old male patient with stage IV proliferative sickle cell retinopathy, treated with one intravitreal injection of ranibizumab, showing regression of the neovascularization and no recurrence at the 9-month follow-up.

Methods.

A 27-year-old male patient presented with blurred vision and floaters in the right eye since three days.

His best corrected visual acuity was 6/18.

Ophthalmological examination and fluorescein angiography revealed proliferative sickle cell retinopathy stage IV with vitreous hemorrhage and sea fan neovascularization, as well as ischemic areas at the temporal periphery.

Results.

The patient was treated with one intravitreal injection of ranibizumab, presenting improvement in the visual acuity from 6/18 to 6/6, resolution of vitreous hemorrhage, and regression of the neovascularization.

Additionally, he underwent scatter laser photocoagulation at the ischemic areas.

At the 9-month follow-up there was no recurrence, while no adverse effects were noticed.

Conclusions.

Intravitreal ranibizumab may be a useful adjunct to laser photocoagulation in the management of proliferative sickle cell retinopathy and may permit some patients to avoid pars plana vitrectomy for vitreous hemorrhage.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Mitropoulos, Panagiotis G.& Chatziralli, Irini P.& Parikakis, Efstratios A.& Peponis, Vasileios G.& Amariotakis, Georgios A.& Moschos, Marilita M.. 2014. Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report. Case Reports in Ophthalmological Medicine،Vol. 2014, no. 2014, pp.1-6.
https://search.emarefa.net/detail/BIM-1034869

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Mitropoulos, Panagiotis G.…[et al.]. Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report. Case Reports in Ophthalmological Medicine No. 2014 (2014), pp.1-6.
https://search.emarefa.net/detail/BIM-1034869

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Mitropoulos, Panagiotis G.& Chatziralli, Irini P.& Parikakis, Efstratios A.& Peponis, Vasileios G.& Amariotakis, Georgios A.& Moschos, Marilita M.. Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report. Case Reports in Ophthalmological Medicine. 2014. Vol. 2014, no. 2014, pp.1-6.
https://search.emarefa.net/detail/BIM-1034869

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1034869